Jenna Scheffert

541 total citations
12 papers, 279 citations indexed

About

Jenna Scheffert is a scholar working on Surgery, Infectious Diseases and Transplantation. According to data from OpenAlex, Jenna Scheffert has authored 12 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Infectious Diseases and 5 papers in Transplantation. Recurrent topics in Jenna Scheffert's work include Transplantation: Methods and Outcomes (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Jenna Scheffert is often cited by papers focused on Transplantation: Methods and Outcomes (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Organ Transplantation Techniques and Outcomes (3 papers). Jenna Scheffert collaborates with scholars based in United States. Jenna Scheffert's co-authors include K. Raza, David M. Salerno, Marcus R. Pereira, Nicholas W. Lange, Douglas L. Jennings, Robert S. Brown, Prabhakar K. Baliga, Kenneth D. Chavin, Charles F. Bratton and Nicole A. Pilch and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Jenna Scheffert

11 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenna Scheffert United States 7 149 101 100 72 35 12 279
Nicholas W. Lange United States 9 70 0.5× 70 0.7× 84 0.8× 37 0.5× 12 0.3× 20 203
Linda J. Stuckey United States 9 106 0.7× 87 0.9× 36 0.4× 93 1.3× 40 1.1× 15 286
Isabel Pérez-Flores Spain 10 67 0.4× 112 1.1× 65 0.7× 34 0.5× 42 1.2× 21 263
Johannes van Hooff Netherlands 9 93 0.6× 275 2.7× 43 0.4× 35 0.5× 26 0.7× 12 381
K. Safdar United States 9 149 1.0× 83 0.8× 21 0.2× 84 1.2× 37 1.1× 16 318
F. Cambra Spain 12 205 1.4× 128 1.3× 32 0.3× 119 1.7× 22 0.6× 32 353
Ricardo Henrique de Oliveira Braga Teixeira Brazil 8 152 1.0× 37 0.4× 33 0.3× 77 1.1× 32 0.9× 30 263
Teresa Bączkowska Poland 9 62 0.4× 109 1.1× 18 0.2× 55 0.8× 41 1.2× 52 275
Sarat Kuppachi United States 11 38 0.3× 64 0.6× 49 0.5× 36 0.5× 90 2.6× 30 258
Nikhil Kapila United States 7 82 0.6× 134 1.3× 26 0.3× 81 1.1× 35 1.0× 22 264

Countries citing papers authored by Jenna Scheffert

Since Specialization
Citations

This map shows the geographic impact of Jenna Scheffert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna Scheffert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna Scheffert more than expected).

Fields of papers citing papers by Jenna Scheffert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenna Scheffert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna Scheffert. The network helps show where Jenna Scheffert may publish in the future.

Co-authorship network of co-authors of Jenna Scheffert

This figure shows the co-authorship network connecting the top 25 collaborators of Jenna Scheffert. A scholar is included among the top collaborators of Jenna Scheffert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenna Scheffert. Jenna Scheffert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Salerno, David M., et al.. (2024). Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation. Clinical Transplantation. 38(8). e15420–e15420.
2.
Salerno, David M., Douglas L. Jennings, Nicholas W. Lange, et al.. (2022). Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American Journal of Transplantation. 22(8). 2083–2088. 57 indexed citations
3.
Nakagawa, Shunichi, Jonathan P. Singer, Yuan Zhang, et al.. (2022). Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool. Transplantation Proceedings. 54(10). 2680–2687. 3 indexed citations
4.
Lange, Nicholas W., et al.. (2022). Elevated posaconazole trough concentrations are not associated with increased risk for posaconazole toxicity in lung transplant recipients. Clinical Transplantation. 37(1). e14826–e14826. 4 indexed citations
5.
Salerno, David M., et al.. (2021). Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients. Clinical Transplantation. 35(3). e14213–e14213. 9 indexed citations
6.
Salerno, David M., Nicholas W. Lange, Hilary Robbins, et al.. (2021). Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients. Clinical Transplantation. 35(12). e14396–e14396. 5 indexed citations
7.
Liu, Esther, et al.. (2020). Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(1). 59–76. 8 indexed citations
8.
Aversa, Meghan, Luke Benvenuto, Michaela R. Anderson, et al.. (2020). COVID-19 in lung transplant recipients: A single center case series from New York City. American Journal of Transplantation. 20(11). 3072–3080. 49 indexed citations
9.
Tsapepas, Demetra, et al.. (2014). Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center. Diagnostic Microbiology and Infectious Disease. 81(4). 299–304. 13 indexed citations
10.
Scheffert, Jenna & K. Raza. (2014). Immunosuppression in lung transplantation.. PubMed. 6(8). 1039–53. 101 indexed citations
11.
Scheffert, Jenna, David J. Taber, Nicole A. Pilch, et al.. (2013). Clinical Outcomes Associated With the Early Postoperative Use of Heparin in Pancreas Transplantation. Transplantation. 97(6). 681–685. 27 indexed citations
12.
Scheffert, Jenna, David J. Taber, Nicole A. Pilch, et al.. (2013). Timing of Factor VII a in Liver Transplantation Impacts Cost and Clinical Outcomes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(5). 483–488. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas W. Lange Breakdown of academic impact, for papers by Linda J. Stuckey Breakdown of academic impact, for papers by Isabel Pérez-Flores Breakdown of academic impact, for papers by Johannes van Hooff Breakdown of academic impact, for papers by K. Safdar Breakdown of academic impact, for papers by F. Cambra Breakdown of academic impact, for papers by Ricardo Henrique de Oliveira Braga Teixeira Breakdown of academic impact, for papers by Teresa Bączkowska Breakdown of academic impact, for papers by Sarat Kuppachi Breakdown of academic impact, for papers by Nikhil Kapila
Rankless by CCL
2026